Evidence map›Paper›PMID 36223158›Full record

ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2022

Factors associated with high health care spending among patients with schizophrenia.

Andrew J Stewart, Scott Patten, Kirsten M Fiest, Tyler S Williamson, James P Wick, Paul E Ronksley

Abstract read
In one paragraph

Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Heat Resilience and Severe & Persistent Mental Illness.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrew J StewartDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Scott PattenDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Kirsten M FiestDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Tyler S WilliamsonDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
James P WickDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Paul E RonksleyDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUnderstanding the reasons for the wide variation in health care spending among patients with schizophrenia may benefit the development of interventions aimed at improving patient outcomes and health care spending efficiency. The aim of our study was to determine factors associated with high health care spending in the patient population.

methodsA serial cross-sectional study used the administrative health records of residents of Alberta, Canada between 1 January 2008 and 31 December 2017 and provincial costing methodologies to calculate total health care spending and sector-specific costs. Factors that modified the odds of being a high cost (i.e. 95th percentile or higher) patient with schizophrenia were estimated using generalized estimating equations.

resultsThis study captured 242 818 person-years of observations among 38 177 unique patients with schizophrenia. Increased odds of being a high-cost patient were associated with younger age (18-29 years), male sex, unstable housing status and requiring care from multiple medical specialties. The strongest estimated associations between high cost status and comorbidity were for metastatic cancer (OR = 2.26) and cirrhosis (OR = 2.07). In contrast, polypharmacy was associated with a decreased odds of being high cost compared with untreated patients.

conclusionFactors associated with being a high-cost patient are the result of complex interactions between individual, structural and treatment-related factors. Efforts to improve patient outcomes and address rising health care costs must consider the value of allocating resources towards early detection and support of patients with schizophrenia along with the prevention/management of comorbidity.

Indexed as

SchizophreniaAdolescentAdultAlbertaCross-Sectional StudiesHealth Care CostsHealth ExpendituresHumansMaleYoung Adultcomorbidityhealth care expenditureshealth services researchschizophrenia

Identifiers

PMID36223158
PMCPMC9584173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.